Invesco
XFOR icon

Invesco’s X4 Pharmaceuticals XFOR Stock Holding History

Invesco’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452K Buy
96,772
+76,804
+385% +$315K ﹤0.01% 3282
2026
Q1 		$82.5K Buy
+19,968
New +$74.8K ﹤0.01% 3648
2025
Q2 		– Sell
-1,940
Closed -$13.8K – 3890
2025
Q1 		$13.8K Sell
1,940
-129
-6% -$1.78K ﹤0.01% 3754
2024
Q4 		$45.5K Sell
2,069
-2,057
-50% -$32.8K ﹤0.01% 3698
2024
Q3 		$82.8K Buy
4,126
+840
+26% +$17.5K ﹤0.01% 3644
2024
Q2 		$57.2K Sell
3,286
-1
-0% -$33 ﹤0.01% 3808
2024
Q1 		$137K Buy
3,287
+73
+2% +$2.03K ﹤0.01% 3713
2023
Q4 		$80.9K Buy
3,214
+513
+19% +$12.5K ﹤0.01% 3709
2023
Q3 		$88.3K Buy
2,701
+316
+13% +$13.8K ﹤0.01% 3734
2023
Q2 		$139K Buy
2,385
+1,387
+139% +$71.3K ﹤0.01% 3678
2023
Q1 		$26.1K Buy
998
+478
+92% +$14K ﹤0.01% 3799
2022
Q4 		$15.5K Buy
+520
New +$24.6K ﹤0.01% 3989

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's XFOR Position: Q2 2026 in Review

Invesco increased its X4 Pharmaceuticals (XFOR) stake by 385% in Q2 2026, buying an estimated $315K and bringing the position to 96,772 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #3282.

Invesco first reported a position in XFOR in Q4 2022 and has held it in 12 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Invesco held 96,772 shares of X4 Pharmaceuticals worth $452K as of Q2 2026.
  • Invesco bought 76,804 X4 Pharmaceuticals shares in Q2 2026, an estimated $315K.
  • X4 Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3282 holding.
  • Invesco first reported a position in X4 Pharmaceuticals in Q4 2022 and has held it in 12 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.